assessment-resistance-to-tyrosine-kinase-inhibitors-an-interrogation

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays

Cancer patients with an aberrant regulation of the protein phosphorylation networks are often treated with the tyrosine kinase inhibitors. Response rates ...

University of Southern California

Combined androgen blockade therapy (CAB) has been shown to have a small survival advantage over luteinizing hormone releasing hormone LH-RH agonists (LH-RHa) alone in men with metastatic prostate cancer. The goal of this study was to assess the cost-effectiveness of CAB with bicalutamide and LH-RH agonist therapy to LH-RH agonist therapy alone.

The cost-effectiveness of combined androgen blockade with bicalutamide and luteinizing hormone releasing hormone agonist in men with metastatic prostate cancer.

Lauren Clarke

Lawrence J. Ellison Institute for Transformative Medicine,
Center for Applied Molecular Medicine,
Lawrence J. Ellison Institute for Transformative Medicine, Center for Applied Molecular Medicine

University of Southern California

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays

Lauren Clarke

.css-o250i3{font-size:18px;font-family:Open Sans,sans-serif;line-height:21.6px;}Lawrence J. Ellison Institute for Transformative Medicine,Center for Applied Molecular Medicine,Lawrence J. Ellison Institute for Transformative Medicine, Center for Applied Molecular Medicine

University of Southern California

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays

Lawrence J. Ellison Institute for Transformative Medicine,
Center for Applied Molecular Medicine,
Lawrence J. Ellison Institute for Transformative Medicine, Center for Applied Molecular Medicine